Jeffrey H. Hanke

Discovery of a Novel, Potent, and Src Family-selective Tyrosine Kinase Inhibitor

Jeffrey H. Hanke, Joseph P. Gardner, Robert L. Dow et al. · Journal of Biological Chemistry · 1996 · 2K citations · Full text

Life Sciences, Immunology, Pharmacology +17

Niraparib activates interferon signaling and potentiates anti-PD-1 antibody efficacy in tumor models

Zebin Wang, Kaiming Sun, Yonghong Xiao et al. · Scientific Reports · 2019 · 261 citations · Full text

Medicine, Oncology, Pharmacology +17

D4-GDI, a Substrate of CPP32, Is Proteolyzed during Fas-induced Apoptosis

Songqing Na, Tsung‐Hsien Chuang, Ann Cunningham et al. · Journal of Biological Chemistry · 1996 · 214 citations · Full text

Life Sciences, Biochemistry, Molecular Biology +17

A comparative pharmacokinetic study of PARP inhibitors demonstrates favorable properties for niraparib efficacy in preclinical tumor models

Kaiming Sun, Keith Mikule, Zebin Wang et al. · Oncotarget · 2018 · 183 citations · Full text

Medicine, Oncology, Pharmacology +17

Molecular cloning, expression, and chromosome 19 localization of a human Ro/SS-A autoantigen.

D P McCauliffe, Fritz Lux, T S Lieu et al. · Journal of Clinical Investigation · 1990 · 172 citations · Full text

Life Sciences, Genetics, Molecular Biology +13